Τόμος 15 (2001) – Τεύχος 3 – Άρθρο 13 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 3 – Article 13 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1.       Department of Pathology, Medical School, University of Athens, 75 Mikras Asias str., 115 27 Athens, Greece

2.    Laboratory of Cell Proliferation & Ageing, Institute of Biology, N.C.S.R. Demokritos, 153 10 Athens, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.    Hayflick L., Moorhead P.S.: The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585-621 (1961)

3.    Finlay G.J., Baguley B.C., Wilson W.R.: A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal. Biochem. 139: 272-277 (1984)

4.    Oliver M.H., Harrison N.K., Bishop J.E., Cole P.J., Laurent G.J.: A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92: 513-518 (1989)

5.    Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladjno M.A.,Jr., Shepard H.M.: Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945 (1985)

6.    Laughton C.: Quantification of attached cells in microtiter plates based on Coomassie Brilliant Blue G-250 staining of total cellular protein. Anal. Biochem. 140: 417-423 (1984)

7.    Rubinstein L.V., Shoemaker R.H., Pauli K.D., Simon R.M., Tosini S., Skehan P., Scudiero D.A., Monks A., Boyd M.R.: Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst. 82: 1113-1118 (1990)

8.    Lowik C.W., Alblas M.J., Van de Ruit M., Papapoulos S.E., Van der Pluijm G.: Quantification of adherent and nonadherent cells cultured in 96-well plates using the supravital stain neutral red. Anal Biochem. 213: 426-433 (1993)

9.    Leeder J.S., Dosch H.M., Harper P.A., Lam P., Spielberg S.P.: Fluorescence-based viability assay for studies of reactive drug intermediates. Anal Biochem 177: 364-372 (1989)

10.  Trost L.C., Lem asters J.J.: A cytotoxicity assay for tumor necrosis factor employing a multiwell fluorescence scanner. Anal Biochem 220: 149-153 (1994)

11.  Begg A.C., Mooren E.: Rapid fluorescence-based as-say for radiosensitivity and chemosensrtivity testing in mammalian cells in vitro. Cancer Res. 49: 565-569 (1989)

12.  Ross D.D., Joneckis C.C., Ordonez J.V., Sisk A.M., Wu R.K., Hamburger A.W., Nora R.E.: Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number. Cancer Res. 49: 3776-3782 (1989)

13.  Mosmann T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55-63 (1983)

14.  Alley M.C., Scudiero D., Monks A,, Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48: 589-601 (1988)

15.  Scudiero D., Shoemaker R.H., Pauli K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R.: Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines. Cancer Res. 48: 4827-4833 (1988)

16.  Denizot F., Lang R.: Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89: 271-277 (1986)

17.  Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R.: Tetrazolium-based Assays for Cellular Viability: A Critical Examination of Selected Parameters Affecting Formazan Production. Cancer Res. 51: 2515-2520 (1991)

18.  Jost L.M., Kirkwood J.M., Whiteside T.L.: Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J. Immunol. Meth. 147: 153-165 (1992)

19.  Freshney R.L, Paul J., Kane I.M.: Assay of anti-cancer drugs in tissue culture: Conditions affecting their ability to incorporate ³H-leucine after drug treatment. Br. J. Cancer 31: 89-99 (1975)

20.  Freshney R.I., Morgan D.: Radioisotopic quantitation in microtitration plates by an autofluorographic method. Cell Biol. Int. Rep. 2: 375-380 (1978)

21.  Gratzner H.G.: Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474-475 (1982)

22.  Erba E., Vaghi M., Pepe S., Amato G., Bistolfi M., Ube- zio P., Mangioni C., Landoni F., Morasca L: DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies. Br. J. Cancer 52: 565-573 (1985)

23.  D’lncalci M., Torti L., Damia G., Erba E., Morasca L., Garattini S.: Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide. Cancer Res. 43: 5674-5680 (1983)

24.  Crissman H.A., Steinkamp J.A.: A new method for rapid and sensitive detection of bromodeoxyuridine in DNA-replicating cells. Exp. Cell Res. 173: 256-261 (1987)

25.  Zeile G.: Intracytoplasmic immunofluorescence in multiple myeloma. Cytometry 1: 37-41 (1980)

26.  Grankvist K., Lernmark A., Taljedal I.B.: Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells. J. Endocrinol. Invest. 2: 139-145 (1979)

27.  Weisenthal L.M., Marsden J.A., Dili P.L, Macaluso C.K.: A novel dye exclusion method for testing in vitro chemosensrtivity of human tumors. Cancer Res. 43: 749- 757 (1983)

28.  Krause A.W., Carley W.W., Webb W.W.: Fluorescent labelled B is preferable to trypan blue as a vital exclusion dye for mammalian cells in monolayer culture. J. Histochem. Cytochem. 32: 1084-1090 (1984)

29.  Fisher G., Rice G.C., Hahn G.M.: Dansyl lysine, a new probe for assaying heat-induced cell killing and thermotolerance in vitro and in vivo. Cancer Res. 46: 5064-5067 (1986)

30.  Clark R.A., Kiebanoff S.J., Einstein A.B., Fefer A.: Per- oxidase-H₂O₂-halide system: Cytotoxic effect on mammalian tumor cells. Blood 45: 161-170 (1975)

31.  Detrick-Hooks B., Borsos T., Rapp, H.J.: Quantitative comparison of techniques used to measure complement- mediated cytotoxicity of nucleated cells. J. Immunol. 114: 287-290 (1975)

32.  Cui J., Bystryn J.C.: An improved europium release assay for complement-mediated cytolysis. J. Immunol. Methods 147: 13-19 (1992)

33.  Roper P.R., Drewinko B.: Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res. 36: 2182-2188 (1976)

34.  Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E.A., Longthorne V.L., Culhane A.C., Williams G.T.: Apoptosis: molecular regulation of cell death, Eur. J. Bio-chem. 236: 19-44 (1996)

35.  Wyllie A.H.: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556 (1980)

36.  Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassota P., Traganos F.: Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808 (1992)

37.  Gavriel Y., Sherman Y., Ben-Sasson S.A.: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501 (1992)

38.  Li X., Traganos F., Darzynkiewicz Z.: Simultaneous analysis of DNA replication and apoptosis during treatment of HL-60 cells with camptothecin and hyperthermia and mitogen stimulation of human lymphocytes. Cancer Res. 54: 4289-4293(1994)

39.  Koopman G., Reutelingsperger C.P.M., Kuijten G.A.M., Keehnen R.M.J., Pals S.T., Van Oers M.H.J.: Annexin V for flow cytometry detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420 (1994)

40.  Vermes f., Haanen C., Steffens-Nakken H., Reuteling-sperger C.P.M.: A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184: 39-51 (1995)

41.  Reid S., Cross R., Snow E.C.: Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J. Immunol. Methods 192: 43-54 (1996)

42.  Grady L.H., Nonneman D.J., Rottinghaus G.E., Welshons W.V.: pH-dependent cytotoxicity of contaminants of phenol red for MCF-7 breast cancer cells. Endocrinology 129: 3321-3330 (1991)

43.  Lippman M., Monaco M.E., Bolan G.: Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 37: 1901- 1907 (1977)

44.  Coradini D., Biffi A., Cappelletti V., Di Fronzo G.: Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells. Anticancer Res. 14: 1059-1064 (1994)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr